drugset / Trial / NCT05925036

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

NCT05925036

Phase 1 Recruiting 40 enrolled VA Office of Research and Development
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to test whether adult stem cells, called mesenchymal stem cells (MSCs) collected from the patient's bone marrow can help reduce pain caused by chronic pancreatitis and improve pancreatic function.

Timeline

Start
2024-01-01
Primary completion
2026-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy